Actively Recruiting
Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Led by Epiliquid Holding, Inc · Updated on 2025-09-11
3200
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CLIMBED (Colon cancer Liquid biopsy Investigation of Methylation-based Biomarkers Evaluation using Delta-HLD) is a non-randomized, observational, cross-sectional clinical validation study designed to assess the performance of Delta-HLD, Epiliquid's proprietary liquid biopsy technology, for colorectal cancer (CRC) detection. The study will evaluate the test performance in an average-risk population for CRC undergoing screening colonoscopy, which will serve as the gold standard reference.
CONDITIONS
Official Title
Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women aged 45-75 years
- Scheduled for colorectal cancer screening colonoscopy by treating physician
You will not qualify if you...
- First-degree family history of colorectal cancer
- Inflammatory bowel disease (ulcerative colitis, Crohn's disease)
- Other malignancies within 5 years
- Known hereditary colorectal cancer syndromes (Lynch syndrome, familial adenomatous polyposis)
- Major trauma, surgery, or transfusion in past 30 days
- Current participation in an interventional clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Epiliquid
Mendoza, Mendoza Province, Argentina, 5500
Actively Recruiting
Research Team
D
Dr. Victoria Bocanegra, MD, PhD.
CONTACT
D
Dr. Emanuel Campoy, PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here